Genentech, Inc. patent applications published on March 21st, 2024

From WikiPatents
Jump to navigation Jump to search

Summary of the patent applications from Genentech, Inc. on March 21st, 2024

Genentech, Inc. has recently filed patents for innovative technologies in the fields of antiviral therapies, cell culture media optimization, bispecific antigen-binding molecules for cancer treatment, and interleukin-33 antibodies for IL-33 mediated disorders. These patents cover methods of treating or preventing human cytomegalovirus infection, providing cell culture media for efficient cell growth and polypeptide production, developing bispecific antigen-binding molecules for targeted cancer therapy, and creating IL-33 antibodies for treating IL-33 mediated disorders like ocular diseases.

Summary of notable applications:

  • Development of new antiviral therapies targeting human cytomegalovirus infection.
  • Optimization of cell culture media for enhanced cell growth and polypeptide production.
  • Utilization of bispecific antigen-binding molecules for more precise and effective cancer treatment.
  • Creation of IL-33 antibodies for treating IL-33 mediated disorders, particularly ocular diseases like AMD.



Patent applications for Genentech, Inc. on March 21st, 2024

VIAL ASSEMBLY WITH LUER FITTING (18510516)

Main Inventor

Geoffrey WISE


METHODS OF TREATING ACUTE MYELOID LEUKEMIA AND MANAGING CYTOPENIA (18501909)

Main Inventor

Ahmed Hamed SALEM


ANTI-INTERLEUKIN-33 ANTIBODIES AND USES THEREOF (18364185)

Main Inventor

Gerald R. NAKAMURA


BISPECIFIC ANTIGEN-BINDING MOLECULES AND METHODS OF USE (18517327)

Main Inventor

Diego ELLERMAN


CELL CULTURE COMPOSITIONS AND METHODS FOR POLYPEPTIDE PRODUCTION (18497162)

Main Inventor

Natarajan Vijayasankaran


METHODS FOR MODULATING HOST CELL SURFACE INTERACTIONS WITH HUMAN CYTOMEGALOVIRUS (18518715)

Main Inventor

Claudio CIFERRI